- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05971238
Eye Movement Behaviour and Pupil Size in Natural Outdoor and Indoor Scenes
July 24, 2023 updated by: Manuel Spitschan, Technical University of Munich
Characterization of Eye Movement Behaviour and Pupil Size Through Eye-tracking in Natural Outdoor and Indoor Scenes
In this study, the researchers will be using eye tracking and detailed lighting measurements to understand how different types of indoor and outdoor lighting affect the eye movements and pupil sizes of our participants.
Participants will be paired up and undergo six eye tracking sessions, split across two appointments.
Each appointment will involve viewing either indoor or outdoor scenes, and before each session, participants will spend time adapting to the lighting conditions.
Overall, each participant will spend 24 minutes being tracked, and the entire study will take about 2-3 hours to complete.
The investigators expect differences in eye movements and pupil size between indoor and outdoor scenes.
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Estimated)
24
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Alexander Hahn
- Phone Number: +49(0)70716011670
- Email: alexander.hahn@tuebingen.mpg.de
Study Contact Backup
- Name: Manuel Spitschan, PhD
- Email: manuel.spitschan@tuebingen.mpg.de
Study Locations
-
-
-
Tübingen, Germany, 72076
- Recruiting
- Max Planck Institute for Biological Cybernetics
-
Contact:
- Alexander Hahn
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- No previous eye-surgeries or ocular impairments like anisometropia, amblyopia, strabism, cataract, watery eyes or hanging eye lids
- Normal or corrected-to-normal visual acuity (+3dpt. to -5dpt.)
- Normal colour vision
- Normal binocular vision
Exclusion Criteria:
- Any use of medications or drugs that influence photosensitivity or the ability to concentrate
- Excessive alcohol and/or drug use
- Presence of psychiatric disorders
- Poor sleep quality
- Diagnosed with epilepsy
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Eye-tracking, pupillometry and scene rating indoors & outdoors
|
Light conditions in indoor (artificial light) and outdoor (daylight) settings
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Saccade frequency - Indoor scene 1
Time Frame: Baseline
|
Number per second [n/s]
|
Baseline
|
Saccade frequency - Indoor scene 2
Time Frame: Baseline
|
Number per second [n/s]
|
Baseline
|
Saccade frequency - Indoor scene 3
Time Frame: Baseline
|
Number per second [n/s]
|
Baseline
|
Saccade frequency - Outdoor scene 1
Time Frame: Baseline
|
Number per second [n/s]
|
Baseline
|
Saccade frequency - Outdoor scene 2
Time Frame: Baseline
|
Number per second [n/s]
|
Baseline
|
Saccade frequency - Outdoor scene 3
Time Frame: Baseline
|
Number per second [n/s]
|
Baseline
|
Saccade amplitude - Indoor scene 1
Time Frame: Baseline
|
Mean angular distance traveled [°]
|
Baseline
|
Saccade amplitude - Indoor scene 2
Time Frame: Baseline
|
Mean angular distance traveled [°]
|
Baseline
|
Saccade amplitude - Indoor scene 3
Time Frame: Baseline
|
Mean angular distance traveled [°]
|
Baseline
|
Saccade amplitude - Outdoor scene 1
Time Frame: Baseline
|
Mean angular distance traveled [°]
|
Baseline
|
Saccade amplitude - Outdoor scene 2
Time Frame: Baseline
|
Mean angular distance traveled [°]
|
Baseline
|
Saccade amplitude - Outdoor scene 3
Time Frame: Baseline
|
Mean angular distance traveled [°]
|
Baseline
|
Saccade velocity - Indoor scene 1
Time Frame: Baseline
|
Mean peak velocity [°/s]
|
Baseline
|
Saccade velocity - Indoor scene 2
Time Frame: Baseline
|
Mean peak velocity [°/s]
|
Baseline
|
Saccade velocity - Indoor scene 3
Time Frame: Baseline
|
Mean peak velocity [°/s]
|
Baseline
|
Saccade velocity - Outdoor scene 1
Time Frame: Baseline
|
Mean peak velocity [°/s]
|
Baseline
|
Saccade velocity - Outdoor scene 2
Time Frame: Baseline
|
Mean peak velocity [°/s]
|
Baseline
|
Saccade velocity - Outdoor scene 3
Time Frame: Baseline
|
Mean peak velocity [°/s]
|
Baseline
|
Fixation duration - Indoor scene 1
Time Frame: Baseline
|
Mean fixation duration [s]
|
Baseline
|
Fixation duration - Indoor scene 2
Time Frame: Baseline
|
Mean fixation duration [s]
|
Baseline
|
Fixation duration - Indoor scene 3
Time Frame: Baseline
|
Mean fixation duration [s]
|
Baseline
|
Fixation duration - Outdoor scene 1
Time Frame: Baseline
|
Mean fixation duration [s]
|
Baseline
|
Fixation duration - Outdoor scene 2
Time Frame: Baseline
|
Mean fixation duration [s]
|
Baseline
|
Fixation duration - Outdoor scene 3
Time Frame: Baseline
|
Mean fixation duration [s]
|
Baseline
|
Fixation frequency - Indoor scene 1
Time Frame: Baseline
|
Number per minute [n/min]
|
Baseline
|
Fixation frequency - Indoor scene 2
Time Frame: Baseline
|
Number per minute [n/min]
|
Baseline
|
Fixation frequency - Indoor scene 3
Time Frame: Baseline
|
Number per minute [n/min]
|
Baseline
|
Fixation frequency - Outdoor scene 1
Time Frame: Baseline
|
Number per minute [n/min]
|
Baseline
|
Fixation frequency - Outdoor scene 2
Time Frame: Baseline
|
Number per minute [n/min]
|
Baseline
|
Fixation frequency - Outdoor scene 3
Time Frame: Baseline
|
Number per minute [n/min]
|
Baseline
|
Pupil size - Indoor scene 1
Time Frame: Baseline
|
Mean pupil size [mm]
|
Baseline
|
Pupil size - Indoor scene 2
Time Frame: Baseline
|
Mean pupil size [mm]
|
Baseline
|
Pupil size - Indoor scene 3
Time Frame: Baseline
|
Mean pupil size [mm]
|
Baseline
|
Pupil size - Outdoor scene 1
Time Frame: Baseline
|
Mean pupil size [mm]
|
Baseline
|
Pupil size - Outdoor scene 2
Time Frame: Baseline
|
Mean pupil size [mm]
|
Baseline
|
Pupil size - Outdoor scene 3
Time Frame: Baseline
|
Mean pupil size [mm]
|
Baseline
|
Melanopic irradiance - Indoor scene 1
Time Frame: Baseline
|
Irradiance [W/(sqm*nm)]
|
Baseline
|
Melanopic irradiance - Indoor scene 2
Time Frame: Baseline
|
Irradiance [W/(sqm*nm)]
|
Baseline
|
Melanopic irradiance - Indoor scene 3
Time Frame: Baseline
|
Irradiance [W/(sqm*nm)]
|
Baseline
|
Melanopic irradiance - Outdoor scene 1
Time Frame: Baseline
|
Irradiance [W/(sqm*nm)]
|
Baseline
|
Melanopic irradiance - Outdoor scene 2
Time Frame: Baseline
|
Irradiance [W/(sqm*nm)]
|
Baseline
|
Melanopic irradiance - Outdoor scene 3
Time Frame: Baseline
|
Irradiance [W/(sqm*nm)]
|
Baseline
|
Photopic illuminance - Indoor scene 1
Time Frame: Baseline
|
Illuminance [lux]
|
Baseline
|
Photopic illuminance - Indoor scene 2
Time Frame: Baseline
|
Illuminance [lux]
|
Baseline
|
Photopic illuminance - Indoor scene 3
Time Frame: Baseline
|
Illuminance [lux]
|
Baseline
|
Photopic illuminance - Outdoor scene 1
Time Frame: Baseline
|
Illuminance [lux]
|
Baseline
|
Photopic illuminance - Outdoor scene 2
Time Frame: Baseline
|
Illuminance [lux]
|
Baseline
|
Photopic illuminance - Outdoor scene 3
Time Frame: Baseline
|
Illuminance [lux]
|
Baseline
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Subjective scene ratings - Indoor scene 1
Time Frame: Baseline
|
|
Baseline
|
Subjective scene ratings - Indoor scene 2
Time Frame: Baseline
|
|
Baseline
|
Subjective scene ratings - Indoor scene 3
Time Frame: Baseline
|
|
Baseline
|
Subjective scene ratings - Outdoor scene 1
Time Frame: Baseline
|
|
Baseline
|
Subjective scene ratings - Outdoor scene 2
Time Frame: Baseline
|
|
Baseline
|
Subjective scene ratings - Outdoor scene 3
Time Frame: Baseline
|
|
Baseline
|
Geographical scene location - Indoor scene 1
Time Frame: Baseline
|
Longitude and latitude [°]
|
Baseline
|
Geographical scene location - Indoor scene 2
Time Frame: Baseline
|
Longitude and latitude [°]
|
Baseline
|
Geographical scene location - Indoor scene 3
Time Frame: Baseline
|
Longitude and latitude [°]
|
Baseline
|
Geographical scene location - Outdoor scene 1
Time Frame: Baseline
|
Longitude and latitude [°]
|
Baseline
|
Geographical scene location - Outdoor scene 2
Time Frame: Baseline
|
Longitude and latitude [°]
|
Baseline
|
Geographical scene location - Outdoor scene 3
Time Frame: Baseline
|
Longitude and latitude [°]
|
Baseline
|
Ambient temperature - Indoor scene 1
Time Frame: Baseline
|
Temperature [°C]
|
Baseline
|
Ambient temperature - Indoor scene 2
Time Frame: Baseline
|
Temperature [°C]
|
Baseline
|
Ambient temperature - Indoor scene 3
Time Frame: Baseline
|
Temperature [°C]
|
Baseline
|
Ambient temperature - Outdoor scene 1
Time Frame: Baseline
|
Temperature [°C]
|
Baseline
|
Ambient temperature - Outdoor scene 2
Time Frame: Baseline
|
Temperature [°C]
|
Baseline
|
Ambient temperature - Outdoor scene 3
Time Frame: Baseline
|
Temperature [°C]
|
Baseline
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Manuel Spitschan, PhD, Technical University of Munich & Max Planck Institute for Biological Cybernetics
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
July 1, 2023
Primary Completion (Estimated)
August 31, 2023
Study Completion (Estimated)
July 31, 2024
Study Registration Dates
First Submitted
June 5, 2023
First Submitted That Met QC Criteria
July 24, 2023
First Posted (Actual)
August 2, 2023
Study Record Updates
Last Update Posted (Actual)
August 2, 2023
Last Update Submitted That Met QC Criteria
July 24, 2023
Last Verified
July 1, 2023
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- MPI-TSCN-2023-NATURALEYE
- 2023-231-S-KH (Other Identifier: Ethikkommission der Technischen Universität München)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
YES
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Light Sensitivity
-
The University of Texas Medical Branch, GalvestonCompletedLight SensitivityUnited States
-
University of MichiganTerminated
-
Istanbul University - Cerrahpasa (IUC)Completed
-
Mental Health Services in the Capital Region, DenmarkElforskRecruiting
-
University of BaselHorizon 2020 - European CommissionNot yet recruitingLight FlashingSwitzerland
-
Mohamed samy El-sayedCompletedLight Fluorescence DeviceEgypt
-
LightGuardSuspended
-
Brigham and Women's HospitalRecruitingLight Exposure | Meal TimingUnited States
-
AllerganCompletedBlue Light DamageUnited States
-
Millennium Pharmaceuticals, Inc.CompletedLight-Chain AmyloidosisUnited States, Canada, France, Germany, Italy
Clinical Trials on Indoor vs. outdoor scenes
-
University of MinnesotaRecruitingChildhood Cancer | Hematoietic Cell TransplantUnited States
-
Lithuanian University of Health SciencesRecruitingCoronary Artery Disease | Cardiac Rehabilitation | Cognitive Function 1, Social | Stress Reaction | Nature, HumanLithuania
-
Hong Kong Baptist UniversityRecruitingDepressive SymptomsHong Kong
-
University of CyprusCyprus University of Technology; University of Crete; Soroka University Medical... and other collaboratorsCompletedAtrial Fibrillation | Asthma in ChildrenIsrael, Cyprus, Greece
-
University of PennsylvaniaCenters for Disease Control and PreventionCompletedBehavior, HealthUnited States
-
The Hong Kong Polytechnic UniversityCompleted